Treatment or surveillance for CIN2? : Women now have better data on regression and progression to help them decide
| dc.contributor.author | Cruickshank, Margaret | |
| dc.contributor.institution | University of Aberdeen.Medical Education | en |
| dc.date.accessioned | 2019-02-27T00:04:46Z | |
| dc.date.available | 2019-02-27T00:04:46Z | |
| dc.date.embargoedUntil | 2019-02-27 | |
| dc.date.issued | 2018-02-27 | |
| dc.description | Acknowledgments Jaimie Kavanagh reviewed and contributed to this editorial as a patient representative and volunteer for Jo’s Cervical Cancer Trust. | en |
| dc.description.status | Non peer reviewed | en |
| dc.format.extent | 2 | |
| dc.format.extent | 831042 | |
| dc.identifier | 116554518 | |
| dc.identifier | 902a20a2-621a-408f-b724-10d0ff3b0ed4 | |
| dc.identifier | 29487080 | |
| dc.identifier | 29487080 | |
| dc.identifier | 85042693794 | |
| dc.identifier.citation | Cruickshank, M 2018, 'Treatment or surveillance for CIN2? Women now have better data on regression and progression to help them decide', BMJ, vol. 360, k771, pp. 1-2. https://doi.org/10.1136/bmj.k771 | en |
| dc.identifier.doi | 10.1136/bmj.k771 | |
| dc.identifier.issn | 0959-8146 | |
| dc.identifier.other | ORCID: /0000-0002-8893-8620/work/102132225 | |
| dc.identifier.uri | http://hdl.handle.net/2164/11964 | |
| dc.identifier.vol | 360 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | BMJ | en |
| dc.subject | Editorial | en |
| dc.subject | R Medicine (General) | en |
| dc.subject.lcc | R1 | en |
| dc.title | Treatment or surveillance for CIN2? : Women now have better data on regression and progression to help them decide | en |
| dc.type | Journal item | en |